IDEXX Laboratories, Inc. (LON:0J8P)
544.61
+9.69 (1.81%)
At close: Jul 10, 2025
IDEXX Laboratories Revenue
IDEXX Laboratories had revenue of $998.43M USD in the quarter ending March 31, 2025, with 3.56% growth. This brings the company's revenue in the last twelve months to $3.93B, up 5.56% year-over-year. In the year 2024, IDEXX Laboratories had annual revenue of $3.90B with 6.46% growth.
Revenue (ttm)
$3.93B
Revenue Growth
+5.56%
P/S Ratio
10.44
Revenue / Employee
$357.44K
Employees
11,000
Market Cap
31.78B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
IDEXX Laboratories News
- 5 days ago - Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years - Benzinga
- 18 days ago - IDEXX Laboratories to Release 2025 Second Quarter Financial Results - Business Wire
- 5 weeks ago - Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders - PRNewsWire
- 5 weeks ago - What Does the Market Think About IDEXX Laboratories? - Benzinga
- 2 months ago - IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits - Seeking Alpha
- 2 months ago - IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day - Business Wire
- 2 months ago - IDEXX Laboratories (IDXX) Announces Key Amendments to Corporate Structure - GuruFocus
- 2 months ago - IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha